Patient Guide: A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 56 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05645692
Status: ACTIVE_NOT_RECRUITING
Condition: Urothelial Cancer
Phase: PHASE2

Where You Can Participate

This study is available at 56 locations across the country.

Top locations include:
  • • Cleveland, Ohio
  • • Houston, Texas
  • • Macquarie Park, New South Wales
  • • And 53 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer - Join Clinical Trial NCTNCT05645692

How to Join This Clinical Trial - NCTNCT05645692

Learn how to participate in this PHASE2 trial studying an investigational therapy for Urothelial Cancer. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Urothelial Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Urothelial Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05645692 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 56 locations. Find a study site near you:

Clinical Research Site

Cleveland, Ohio 44106 - United States

Status: Contact for availability

Clinical Research Site

Houston, Texas 77030 - United States

Status: Contact for availability

Clinical Research Site

Macquarie Park, New South Wales 2113 - Australia

Status: Contact for availability

Clinical Research Site

Adelaide, South Australia 5112 - Australia

Status: Contact for availability

Clinical Research Site

Kurralta Park, South Australia 5037 - Australia

Status: Contact for availability

Clinical Research Site

Curitiba, Paraná 80440-220 - Brazil

Status: Contact for availability

Clinical Research Site

Porto Alegre, Rio Grande do Sul 90035-903 - Brazil

Status: Contact for availability

Clinical Research Site

Porto Velho, Rondônia 76834-899 - Brazil

Status: Contact for availability

Clinical Research Site

Santo André, São Paulo 09060-650 - Brazil

Status: Contact for availability

Clinical Research Site

São Paulo, São Paulo 01323-903 - Brazil

Status: Contact for availability

And 46 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Urothelial Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships